Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
187.18
+4.16 (2.27%)
Oct 8, 2025, 4:00 PM EDT - Market closed
Krystal Biotech Market Cap
Krystal Biotech has a market cap or net worth of $5.42 billion as of October 8, 2025. Its market cap has increased by 2.39% in one year.
Market Cap
5.42B
Enterprise Value
4.61B
1-Year Change
2.39%
Ranking
Category
Stock Price
$187.18
Market Cap Chart
Since September 20, 2017, Krystal Biotech's market cap has increased from $92.40M to $5.42B, an increase of 5,763.15%. That is a compound annual growth rate of 65.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 5.30B | 17.57% |
| Dec 31, 2024 | 4.51B | 28.76% |
| Dec 29, 2023 | 3.50B | 71.56% |
| Dec 30, 2022 | 2.04B | 31.13% |
| Dec 31, 2021 | 1.56B | 31.54% |
| Dec 31, 2020 | 1.18B | 23.37% |
| Dec 31, 2019 | 958.50M | 219.71% |
| Dec 31, 2018 | 299.80M | 178.37% |
| Dec 29, 2017 | 107.70M | 16.56% |
| Sep 20, 2017 | 92.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |